Dr. Drew On Call

Driven by current events, "Dr. Drew" on HLN focuses on the human - and human behavior - at the center of the story.

Study: New drug promising for Alzheimer's patients

NEED TO KNOW
  • The drug ORM-12741 designed to target a specific receptor in the brain that responds to stressful situations
  • Patients who took new drug showed a 4 percent improvement in memory score
Study: New drug promising for Alzheimer's patients

A new drug may help people struggling with moderate Alzheimer's disease, a new study says.

During a three-month trial period, Finnish researchers studied the effects of the drug ORM-12741 on 100 patients.

ORM-12741 was designed to target a specific receptor in the brain that responds to stressful situations, HealthDay News reports.

During the study, 50 patients were given a placebo, but the other 50 were given ORM-12741 either in a high or low dose. All the patients using the new drug were using it on top of existing Alzheimer's medications they were currently taking to help with their memory.

Looking at the results from computerized memory tests, researchers saw that patients who took the new drug showed a 4 percent improvement as it related to their memory score.

Catherine Roe at the Washington University School of Medicine in St. Louis tells MyHealth, "This is really a new approach, in terms of the biology that they're targeting. And they showed significant results after only three months of treatment, which is exciting particularly because this drug combination was tested on people who had moderate Alzheimer's disease."

The Cleveland Clinic says that Alzheimer’s disease is caused by the abnormal build-up of proteins in the brain.

The Clinic notes that nearly half of people older than 85 have Alzheimer’s disease. But there are preventative measures that an individual can take that include mental activity, education, physical activity and the Mediterranean diet or another healthy diet that includes antioxidants.

The research is still seen as preliminary. More testing needs to be done before the results are seen as conclusive.

Join the conversation...

HLNtv.com welcomes a lively and courteous discussion as long as you follow the Rules of Conduct set forth in our Terms of Service. Comments are not pre-screened before they post. You agree that anything you post may be used, along with your name and profile picture, in accordance with our Privacy Policy and the license you have granted pursuant to our Terms of Service.
Recall expands: You may want to skip that peach
Health | See all 720 items Recall expands: You may want to skip that peach

Advertisement